Week in Review: This Week's China Pharma Deals Top $1 Billion

20:46 EDT 2 Sep 2017 | ChinaBio Today

Deals and Financings

- Berry Genomics, a Beijing diagnostics/sequencing company, completed a $648 million reverse merger on the Shenzhen exchange;

- China's iPharma agreed in principle to a $120 million deal for Greater China rights to a clinical-stage immunotherapy candidate from Mologen of Berlin;

- Suzhou's CF PharmaTech raised $65 million in a Series D funding to advance its inhalation products;

- aTyr Pharma, a public San Diego-Hong Kong biotherapeutics company, announced a $45.8 million private placement;

- Akeso Biopharma of Zhongshan closed a $45 million B round, led by the GTJA Investment Group, to develop its antibody portfolio;

- Fosun Pharma paid $40 million to acquire a 65% stake in Shanghai SinoMedCare Biotech, a medical marketing company focused on tier 3 China cities;

- Distinct Healthcare of China closed a $40 million C funding round to support its chain of China medical clinics;

- Shuidi, a China crowdfunding platform aimed at helping people pay for healthcare, raised $24 million in a Series A  round led by Tencent Holdings;

Company News

- Beijing's Yisheng Biopharma said its first-in-class immuno-oncology candidate, YS-ON-001, showed "breakthrough" anti-tumor efficacy in pre-clinical tests;

Trials and Approvals

- iCAD, a New Hampshire medical device maker, announced CFDA approval of its balloon applicators, which are used in Brachytherapy treatment of breast cancer.

Stock Symbols: (SHZ: 000710) (F: MGN) (NSDQ: LIFE) (SHA: 600196; HK: 2196) (NSDQ: ICAD)

Share this with colleagues:

Original Article: Week in Review: This Week's China Pharma Deals Top $1 Billion


More From BioPortfolio on "Week in Review: This Week's China Pharma Deals Top $1 Billion"

Quick Search

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...